CVS Health (CVS) Tops Q4 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $101.30 +3.03%
Revenue Growth %: +1.2%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +1.2%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.09, $0.09 better than the analyst estimate of $1.00. Revenue for the quarter came in at $105.7 billion versus the consensus estimate of $103.63 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.00-$7.20, versus the consensus of $7.17.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- ZenaTech raises Plurilock Security stake to 12% with new share purchase
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
